1 C.1 Diuretic and saluretic activity
1.1 C.1.1 In vitro methods
1.1.1 C.1.1.1 Carbonic anhydrase inhibition in vitro
1.1.1.1 PURPOSE AND RATIONALE
Acetazolamide (Diamox®) was one of the first synthetic non-mercurial diuretics. The mode of action was found to be inhibition of carbonic anhydrase. Carbonic anhydrase is a zinc-containing enzyme that catalyzes the reversible hydration (or hydroxylation) of CO2 to form H2CO3 which dissociates non-enzymatically into HCO3 − and H+. At least three isoenzymes, designated as I, II and II or A, B and C, are known to exist. The chemistry, physiology and pharmacology of carbonic anhydrase has been extensively reviewed by Maren (1967). In spite of the fact that newer diuretics are based on other modes of action, the test for inhibition of carbonic anhydrase should be performed for evaluation of a new compound. Moreover, the specific use of carbonic anhydrase inhibitors as antiglaucoma drugs has been described (Friedland and Maren 1984; Caprioli...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
References
Armstrong JMD, Myers DV, Verpoorte JA, Edsall JT (1966) Purification and properties of human erythrocyte carbonic anhydrase. J Biol Chem 241:5137–5149
Caprioli J (1985) The pathogenesis and medical management of glaucoma. Drug Dev Res 6:193–215
Eveloff J, Swenson ER, Maren TH (1979) Carbonic anhydrase activity of brush border and plasma membranes prepared from rat kidney cortex. Biochem Pharmacol 28:1434–1437
Friedland BR, Maren TH (1984) Carbonic anhydrase: Pharmacology of inhibitors and treatment of glaucoma. In: Pharmacology of the Eye. Handbook Exp Pharmacol 69:279–309
Landolfi C, Marchetti M, Ciocci G, Milanese C (1997) Development and pharmacological characterization of a modified procedure for the measurement of carbonic anhydrase activity. J Pharmacol Toxicol Meth 38:169–172
Maren TH (1960) A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharmacol Exp Ther 130:26–29
Maren TH (1967) Carbonic anhydrase: Chemistry, physiology, and inhibition. Physiol Rev 47:595–781
Philpot FJ, Philpot JSL (1936) A modified colorimetric estimation of carbonic anhydrase. Biochem J 30:2191–2193
Wistrand PJ, Knuuttila K-G (1980) Bovine lens carbonic anhydrases: Purification and properties. Exp Eye Res 30:277–290
Wistrand PJ, Schenholm M, Lönnerholm G (1986) Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalm Visual Sci 27:419–428
References
Burg M, Grantham J, Abromow M, Orloff J (1966) Preparation and study of fragments of single rabbit nephrons. Am. J. Physiol. 210:1293–1298
Gögelein H, Greger R (1984) Single channel recordings from basolateral and apical membranes of renal proximal tubules. Pflügers Arch. 401:424–426
Gögelein H, Greger R (1986a) Na+ selective channels in the apical membrane of rabbit late proximal tubules (pars recta). Pflügers Arch. 406:198–203
Gögelein H, Greger R (1986b) A voltage-dependent ionic channel in the basolateral membrane of late proximal tubules of the rabbit kidney. Pflügers Arch. 407 (Suppl. 2):S142–S148
Gögelein H, Greger R (1987) Properties of single K+ channels in the basolateral membrane of rabbit proximal straight tubules. Pflügers Arch. 410:288–295
Greger R, Hampel W (1981) A modified system for in vitro perfusion of isolated renal tubules. Pflügers Arch. 389:175–176
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:85–100
Heidrich HG, Dew M (1977) Homogeneous cell populations from rabbit kidney cortex. Proximal, distal tubule, and reninactive cells isolated by free-flow electrophoresis. J Cell Biol 74:780–788
Hoyer J, Gögelein H (1991) Sodium-alanine cotransport in renal proximal tubule cells investigated by whole-cell current recording. J Gen Physiol 97:1073–1094
Merot J, Bidet M, Gachot B, LeMaout S, Tauc M, Poujeol P (1988) Patch clamp study on primary culture of isolated proximal convoluted tubules. Pflügers Arch. 413:51–61
Neher E, Sakmann B (1976) Single channel currents recorded from membranes of denervated frog muscle fibres. Nature 260:799–802
Schlatter E (1993) Effect of various diuretics on membrane voltage of macula densa cells. Whole-cell patch-clamp experiments. Pflügers Arch Eur J Physiol 423:74–77
References
Burg MB, Green N (1973) Function of the thick ascending limb of Henle's loop. Am J Physiol 224:659–668
Burg MB, Orloff J (1980) Perfusion of isolated renal tubules. In: Anonymous. (ed) Handbook of Physiology. pp 145–159
Burg M, Stoner L (1976) Renal tubular chloride transport and the mode of action of some diuretics. Ann Rev Physiol 38:37–45
Burg M, Grantham J, Abramow M, Orloff J (1996) Preparation and study of fragments of single rabbit nephrons. Am J Physiol 210:1293–1298
Dillingham MA, Schrier RW, Greger R (1993) Mechanisms of diuretic action. In: Schrier RW, Gottschalk CW. (eds) Clinical Disorders of Fluid, Electrolytes, and Acid Base. Little Brown and Comp, Boston, pp 2435–2452
Frömter E (1984) Viewing the kidney through microelectrodes. Am J Physiol 247:F695–F705
Greger R (1981) Cation selectivity of the isolated perfused cortical thick ascending limb of Henle's loop of rabbit kidney. Pflügers Arch 390:30–37
Greger R (1985) Application of electrical measurements in the isolated in vitro perfused tubule. Mol Physiol 8:11–22
Greger R, Hampel W (1981) A modified system for in vitro perfusion of isolated renal tubules. Pflügers Arch 389:175–176
Greger R, Schlatter E (1983a) Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle's loop. Klin Wochenschr 61:1019–1027
Greger R, Schlatter E (1983b) Properties of the lumen membrane of the cortical thick ascending limb of Henle's loop of rabbit kidney. Pflügers Arch 396:315–324
Nitschke R, Fröbe U, Greger R (1991) ADH increases cytosolic Ca2+-activity in isolated perfused rabbit thick ascending limb via a V1 receptor. Pflügers Arch 417:622–632
Schafer JA, Troutman SL, Andreoli TE (1974) Volume reabsorption, transepithelial potential differences, and ionic permeability properties in mammalian superficial proximal straight tubules. J Gen Physiol 64:582–607
Schlatter E, Greger R, Weidtke C (1983) Effect of “high ceiling” diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney. Correlation of chemical structure and inhibitory potency. Pflügers Arch 396:210–217
Stoner LC, Burg MB, Orloff J (1974) Ion transport in cortical collecting tubule; effect of amiloride. Am J Physiol 227:453–459
Ullrich KJ, Greger R (1985) Approaches to the study of tubule transport functions. In: Seldin DW, Giebisch G. (eds) Physiology and Pathophysiology. Raven Press, New York, pp 427–469
Wangemann P, Wittner M, Di Stefano A, Englert HC, Lang HJ, Schlatter E, Greger R (1986) Cl−-channel blockers in the thick ascending limb of the loop of Henle. Structure activity relationship. Pflügers Arch 407 (Suppl 2):S128–S141
Wittner M, Di Stefano A, Wangemann P, Delarge J, Liegeois JF, Greger R (1987) Analogues of torasemide — structure function relationships. Experiments in the thick ascending limb of the loop of Henle of rabbit nephron. Pflügers Arch 408:54–62
Wittner M, Di Stefano A, Wangemann P, Nitschke R, Greger R, Bailly C, Amiel C, Roinel N, De Rouffignac C (1988) Differential effects of ADH on sodium, chloride, potassium, calcium and magnesium transport in cortical and medullary thick ascending limbs of mouse nephron. Pflügers Arch 412:516–523
References
Cox PGF, Moons MM; Slegers JFG, Russel FGM, van Ginneken CAM (1990) Isolated perfused rat kidney as a tool in the investigation of renal handling and effects of nonsteroidal anti-inflammatory drugs. J Pharmacol Meth 24:89–103
Maack T (1980) Physiological evaluation of the isolated perfused rat kidney. Am J Physiol 238:F71–F78
Newton JF, Hook JB (1981) Isolated perfused rat kidney. Meth Enzymol 77:94–105
Nishiitsutsuji-Uwo JM, Ross BD, Krebs HA (1967) Metabolic activities of the isolated perfused rat kidney. Biochem J 103:852–862
Nizet AH (1978) Methodology for study of isolated perfused dog kidney in vitro. In: Martinez-Maldonado M (ed) Methods in Pharmacology, Vol 4B, Renal Pharmacology pp 369–383. Plenum Press, New York and London
Ross BD (1972) Perfusion techniques in biochemistry. 4. Kidney. Clarendon Press, Oxford, pp 228–257
Schurek HJ (1980) Application of the isolated perfused rat kidney in nephrology. In: Stolte H, Alt J (eds) Contributions to Nephrology 19:176–190. S. Karger, Basel
Tarako T, Nakata K, Kawakami T, Miyazaki Y, Muakami M, Seo Y, Suzuki E (1991) Validation of a toxicity testing model by evaluating oxygen supply and energy state in the isolated perfused rat kidney. J Pharmacol Meth 25:195–204
References
Cummings JR, Haynes JD, Lipchuck LM, Ronsberg MA (1960) A sequential probability ratio method for detecting compounds with diuretic activity in rats. J Pharmacol Exp Ther 128:414–418
Kau ST, Keddie JR, Andrews D (1984) A method for screening diuretic agents in the rat. J Pharmacol Meth 11:67–75
Klatt P, Muschaweck R, Bossaller W, Magerkurth KO, Vanderbeeke O (1997) Method of collecting urine and comparative investigation of quantities excreted by cats and dogs after furosemide. Am J Vet Res 36:919–923
Laycock JF, Chatterji U, Seckl JR, Gartside IB (1994) The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink. Physiol Behav 55:407–412
Lipschitz WL, Hadidian Z, Kerpcsar A (1943) Bioassay of diuretics. J Pharmacol Exp Ther 79:97–110
Muschaweck R, Hajdu P (1964) Die saludiuretische Wirksamkeit der Chlor-N-(2-furylmethyl)-5-sulfamyl-anthranilsäure. Arzneim Forsch 14:44–47
Muschaweck R, Sturm K (1972) Diuretika. In: Ehrhart G, Ruschig H (eds) Arzneimittel. Entwicklung — Wirkung — Darstellung. Vol 2, pp 317–328. Verlag Chemie, Weinheim/Bergstrasse, Germany
Nyunt-Wai V, Laycock JF (1990) The pressor response to vasopressin is not attenuated by hypertonic NaCl in the anaesthetized Brattleboro rat. J Physiol 430:35P
Schmale H, Richter D (1984) Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308:705–709
Schmale H, Ivell M, Breindl D, Darmer D, Richter D (1984) The mutant vasopressin gene from diabetes insipidus (Brattleboro) rats is transcribed but the message is not efficiently translated. EMBO J 3:3289–3293
Szot P, Dorsa DM (1992) Cytoplasmatic and nuclear vasopressin RNA in hypothalamic and extrahypothalamic neurons of the Brattleboro rat: An in situ hybridization study. Mol Cell Neurosci 3:224–236
Valtin H, Sawyer WH, Sokol HW (1965) Neurohypophyseal principles in rats homozygous and heterozygous for hypothalamic diabetes insipidus (Brattleboro strain) Endocrinology 77:701–706
References
Bicking JB, Mason JW, Woltersdorf OW, Jones JH, Kwong SF, Robb CM, Cragoe EJ (1965) Pyrazine diuretics. I. N-amidino-3-amino-6-halopyrazinecarboxamides. J Med Chem 8:638–642
Kagawa CM, Cella JA, Van Arman CG (1957) Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt. Science 126:1015–1016
Muschaweck R, Hajdu P (1964) Die saludiuretische Wirksamkeit der Chlor-N-(2-furylmethyl)-5-sulfamyl-anthranilsäure. Arzneim Forsch/Drug Res 14:44–47
Muschaweck R, Sturm K (1972) Diuretika. In: Ehrhart G, Ruschig H (eds) Arzneimittel. Entwicklung — Wirkung — Darstellung. Vol 2, pp 317–328. Verlag Chemie, Weinheim/Bergstrasse, Germany
References
Baer JE (1965) Animal techniques for evaluating diuretics. In: Nodin HJ, Siegler PE (eds) Animal and Clinical Pharmacologic Techniques in Drug Evaluation. pp 231–236. Year Book Medical Publ. Inc. Chicago
Muschaweck R, Hajdu P (1964) Die saludiuretische Wirksamkeit der Chlor-N-(2-furylmethyl)-5-sulfamyl-anthranilsäure. Arzneim Forsch/Drug Res 14:44–47
Muschaweck R, Sturm K (1972) Diuretika. In: Ehrhart G, Ruschig H (eds) Arzneimittel. Entwicklung — Wirkung — Darstellung. Vol 2, pp 317–328. Verlag Chemie, Weinheim/Bergstrasse, Germany
Suki W, Rector FC, Seldin DW (1965) The site of action of furosemide and other sulfonamide diuretics in the dog. J Clin Invest 44:1458–1469
References
Gabel RA, Ranaei RA, Kivlighn (1996) A new method of measuring renal function in conscious rats without the use of radioisotopes. J Pharmacol Toxicol Meth 36:189–197
Hropot M, Klaus E, Seuring B, Lang HJ (1985) Effects of diuretics on magnesium excretion. Magnesium Bull 7:20–24
Hropot M, Klaus E, Knolle J, König W, Scholz W (1986) Effect of rat atriopeptin III on renal function in dogs during water diuresis and hydropenia. Klin Wochenschr 64 (Suppl VI):58–63
Rönnhedh C, Jaquenod M, Mather LE (1996) Urineless estimation of glomerular filtration rate and renal blood flow in the rat. J Pharmacol Toxicol Meth 36:123–129
Russel FGM, Wouterse AC, Hekman P, Grutters GJ, van Ginneken CAM (1987) Quantitative urine collection in renal clearance studies in the dog. J Pharmacol Meth 17:125–136
Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24:388–393
Suki W, Rector FC Jr., Seldin DW (1965) The site of action of furosemide and other sulfonamide diuretics in the dog. J Clin Invest 44:1458–1469
Tanaka S, Kanda A, Ashida SI (1990) Uricosuric and diuretic activities of DR-3438 in dogs and rabbits. Japan J Pharmacol 54:307–314
Walser M, Davidson DG, Orloff J (1955) The renal clearance of alkali-stable inulin. J Clin Invest 34:1520–1523
References
Duarte CG, Chomety F, Giebisch G (1971) Effect of amiloride, ouabain and furosemide on distal tubular function in the rat. Am J Physiol 221:632–640
Hropot M, Fowler Nicole, Karlmark B, Giebisch G (1985) Tubular action of diuretics: Distal effects on electrolyte transport and acidification. Kidney Int 28:477–489
Knox FG, Marchand GR (1976) Study of renal action of diuretics by micropuncture techniques. In: Martinez-Maldonado M (ed) Methods in Pharmacology, Vol 4A, Renal Pharmacology pp 73–98. Plenum Press, New York and London
References
Malvin RL, Wilde WS, Sullivan LP (1958) Localisation of nephron transport by stop flow analysis. Am J Physiol 194:135–142
Muschaweck R, Sturm K (1972) Diuretika. In: Ehrhart G, Ruschig H (eds) Arzneimittel. Entwicklung — Wirkung — Darstellung. Vol 2, pp 317–328. Verlag Chemie, Weinheim/Bergstrasse, Germany
Shinosaki T, Yonetani Y (1989) Stop-flow studies on tubular transport of uric acid in rats. Adv Exp Med Biol 253A:293–300
Shinosaki T, Harada H, Yonetani Y (1991) Uricosuric property of a new diuretic compound, S-8666-S-(−)-enantiomer. Drug Dev Res 22:153–163
Tanaka S, Kanda A, Ashida SI (1990) Uricosuric and diuretic activities of DR-3438 in dogs and rabbits. Japan J Pharmacol 54:307–314
References
Acott PD, Ogborn MR, Crocker JFS (1987) Chronic renal failure in the rat. A surgical model for long-term-toxicological studies. J Pharmacol Meth 18:81–88
Freeman RM (1971) The role of magnesium in the pathogenesis of azotemic hypothermia. Proc Soc Exp Biol Med 137:1069–1072
Hartenbower DL, Coburn JW (1972) A model of renal insufficiency in the chick. Lab Anim Sci 22:258–261
Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S (1995) Angiotensin II receptor antagonist ameliorates renal tubulo-interstitial fibrosis caused by unilateral ureteral obstruction. Kidney Intern 47:1285–1294
Klahr S, Morrissey JJ (1997) Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Intern 52, Suppl 63:111–114
Sancho JJ, Duh Qy, Oms L, Sitges-Serra A, Hammond ME, Arnaud CD, Clark OH (1989) A new experimental model for secondary hyperparathyroidism. Surgery 106:1002–1008
Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Meth 37:1–7
References
Ali SM, Laping NJ, Fredrickson TA, Contino LC, Olson BA, Anderson K, Brooks DP (1998) Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGFβ1 mRNA expression in rats with chronic renal disease. Pharmacology 57:20–27
Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Cabiki S, Silverberg D, Iaina A (1995) Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 47:1515–1521
Bardoux P, Martin H, Ahoulay M, Schmitt F, Bouby N, Trinh Trang Tan M, Bankir E (1999) Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci USA 96:10397–10402
Barreto-Chaves MLM, Mello-Aires M (1996) Effect of luminal angiotensin II and ANP on early and late cortical distal tubule HCO3-reabsorption. Am J Physiol 271; Renal Fluid Electrolyte Physiol 40:F977–F984
Bonilla-Felix M, Hamm LL, Herndon J, Vehaskari VM (1992) Response of cortical collecting ducts from remnant kidneys to arginine vasopressin. Kidney Int 41:1150–1154
Brochu E, Lacasse MS, Moreau C, Lebel M, Kingma I, Grose JH, Laviviere R (1999) Endothelin in ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrol Dial Transplant 14:1881–1888
Brooks DP, Contino LC, Short BG, Gowan C, Trizna W, Edwards RM (1995) SB 203220: A novel angiotensin II receptor antagonist and renoprotective agent. J Pharmacol Exp Ther 274:1222–1227
Brown JH, Lappin TRJ, Elder EG, Bridges MJ, McGeown MG (1990) The metabolism of erythropoietin in the normal and uremic rabbit. Nephrol Dial Transplant 5:855–859
Christensen S, Marcussen N, Petersen S, Shalmi M (1992) Effects of uninephrectomy and high protein feeding on lithium-induced chronic renal failure in rats. Renal Physiol Biochem 15:141–149
Christensen S, Shalmi M, Hansen AK, Marcussen N (1997) Effects of pepindopril and hydrochlorothiazide on the long-term progression of lithium-induced chronic renal failure in rats. Pharmacol Toxicol 80:132–141
Cohen DS, Mathis JE, Dotson RA, Graybill SR, Wosu NJ (1998) Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure. J Cardiovasc Pharmacol 32:87–95
Cowley Jr. BD, Grantham JJ, Muessel MJ, Kraybill AL, Gattone II VH (1996) Modification of disease progression in rats with inherited polycystic kidney disease. Am J Kidney Dis 27:865–879
Fernadez R, Lopes MJ, De Lira RF, Dantas WFG, Cragoe EJ Jr., Malnic G (1994) Mechanism of acidification along cortical distal tubule of the rat. Am J Physiol 266, Renal Fluid Electrolyte Physiol 35:F218–F226
Fine A, Jones D, Kaushal G, LeFal Y, Sharma G (1990) Remnant model of renal failure in the dog: Avoidance of second surgery by chemical nephrectomy. Clin Invest Med 13:152–154
Garcia de Boto MJ, Cobo A, Rodriguez J, Fernandez P, Rey C, Santos F (1996) Chronic renal failure and human growth hormone treatment do not modify endothelium-dependent reactions in the rat aorta in vitro. J Auton Pharmacol 16:97–103
Fukagawa M, Kaname SY, Igarashi T, Ogata E, Kurokawa K (1991) Regulation of parathyroid hormone synthesis in chronic renal failure in rat. Kidney Int 39:874–881
Hamilton DL, Cotes PM (1994) The effect of the submandibular salivary gland on the erythropoietin response to hypoxia in mice with chronic renal failure. Exp Hematol 22:256–260
Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA (1994) Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 46:58–68
Jarusiripipat C, Chan L, Shapiro JI, Schrier RW (1992) Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats. J Pharmacol Exp Ther 260:243–247
Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A (1992) Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42:46–55
Kimura M, Suzuki T, Hishida A (1999) A rat model of progressive renal failure produced by microembolism. Am J Pathol 155:1371–1380
Kohzuki M, Yasujima M, Yoshida K, Kanazawa M; Abe K (1994) Antihypertensive and antiproteinuric effects of losartan in spontaneously hypertensive rats with chronic renal failure. Hypertens Res Clin Exp 17:173–178
Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K, Saito T, Yasujima M, Sato T, Abe K (1995) Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: Chronic effects on cardio-and renoprotection of angiotensin converting enzyme inhibitors. J Hypertens 13:1785–1790
Koumegawa JI, Nagano N, Arai H, Wada N, Kusaka M, Takahashi A (1991) Anemia in new congenital adult type polycystic kidney mice. J Urol 146:1645–1649
Lariviere R, Lebel M, Kingma T, Grose JH, Boucher D (1998) Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass. AM J Hypertens 11:989–997
Levine DZ, Iacovitti M, Buckman S, Burns KD (1996) Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J Clin Invest 97:120–125
Levine DZ, Iacovitti M, Buckman S, Hinke MT, Luck B, Fryer JN (1997) ANG II-dependent HCO −3 reabsorption in surviving rat renal tubules: expression/activation of H+-ATPase. Am J Physiol 272; Renal Physiol 41:F799–F808
Liu DT, Turner SW; Wen C, Witworth JA (1996) Angiotensin converting enzyme inhibition and protein restriction in progression of experimental chronic renal failure. Pathology 28:156–160
Luk JKH, Wong EFC, Wong NLM (1995) Downregulation of atrial natriuretic factor clearance receptors in experimental chronic failure in rats. Am J Physiol 269; Heart Circ Physiol 38:H902–G908
MacLaughlin M, Monserrat AJ, Muller A, Matoso M, Amorena C (1998) Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure. Kidney Blood Press Res 21:329–334
Mak RHK, Pak YK (1996) End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int 50:400–406
Nabokov A, Amann K, Wagner J, Gehlen F, Munter K, Ritz E (1996) Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. Nephrol Dial Transplant 11:514–520
Noda M, Fukuda R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y (1997) Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney Int Suppl 51/63:S136–S139
Nyengaard JR, Bendtsen TF, Christensen S, Ottosen PD (1994) The number and size of glomeruli in long-term lithium-induced nephropathy in rats. APMIS 102:59–66
Pelayo JC, Quan AH, Shanley PF (1990) Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am J Physiol 258; Renal Fluid Electrolyte Physiol 27:F414–F422
Potter GS, Johnson RJ, Fink GD (1997) Role of endothelin in hypertension of experimental chronic renal failure. Hypertension 30:1578–1584
Poux JM, Lartigue M, Chaisemartin RA, Galen FX, Leroux-Robert C (1995) Uraemia is necessary for erythropoietin-induced hypertension in rats. Clin Exp Pharmacol Physiol 22:769–771
Roczniak A, Fryer JN, Levine DZ, Burns KD (1999) Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J Am Soc Nephrol 10:704–713
Santos F, Chan JCM, Hanna JD, Niimi K, Krieg RJ Jr., Wellons MD (1992) The effect of growth hormone on the growth failure of chronic renal failure. Pediatr Nephrol 6:262–266
Schaefer L, Malchow M, Schaefer RM, Ling H, Heidland A, Massry SG (1996) Effects of parathyroid hormone on renal tubular proteinases. Miner Electrolyte Metabol 22:182–186
Shimizu T, Hata S, Kuroda T, Mihara SI, Fujimoto M (1999) Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats. Eur J Pharmacol 381:39–49
Stockelman MG, Lorenz JN, Smith FN, Boivin GP, Sahota A, Tischfield JA, Stambrook PJ (1998) Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am J Physiol 275; Renal Physiol 44:F154–F163
Tolins JP, Raij L (1990) Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 10:452–461
Tonshoff B, Powell DR. Zhao D, Durham SK, Coleman ME, Domene HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ (1997) Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and-2 gene expression in experimental uremia. Endocrinology 138:938–946
Urena P, Kubrusly M, Mannstadt M, Hruby M, Tan M MTT, Silve C, Lacour B, Abou-Samra AB, Segre GV, Drueke T (1994) The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605–611
Van den Branden, Gabriels M, Vamecq J Houte KV, Verbeelen D (1997) Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status: A comparative study of two β-blocking drugs, carvedilol and propranolol. Nephron 77:319–324
Vaneerdeweg W, Buyssens N, De Winne T, Sebrechts M, Babloyan A, Arakelian S, De Broe ME (1992) A standard surgical technique to obtain a stable and reproducible chronic renal failure model in dogs. Eur Surg Res 24:273–282
Vaziri ND, Oveisi F, Ding Y (1998) Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53:1748–1754
Wolf SC, Brehm Br, Gaschler F, Brehm S, Klaussner M, Smykowski J, Amann K, Osswald H, Erley CM, Risler T (1999) Protective effects of endothelin antagonists in chronic renal failure. Nephrol Dial Transplant 14, Suppl 4:29–30
Wong NLM, Wong EEC (1991) Increased release of atrial natriuretic peptide by the atria of rats with experimental renal failure. Nephron 57:89–93
Wong NLM, Wong EEC (1992) Effect of dietary sodium on atrial natriuretic factor released in rats with chronic renal failure. Nephron 61:464–469
Yi H, Fukagawa M; Yamamoto H, Kumagai M, Watanabe T, Kurokawa K (1995) Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats. Possible direct role of phosphorus. Nephron 70:242–248
Zhou X J, Pandian D, Wang QX, Vaziri ND (1997) Erythropoietin-induced hypertension is not mediated by alterations of plasma endothelin, vasopressin, or atrial natriuretic peptide levels. J Am Soc Nephrol 8:901–905
References
Chen Y-M, Chien C-T, Hu-Tsai M-I, Wu K-D, Tsai C-C, Wu M-S, Tsai T-J (1999) Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Intern 56:932–943
Heymann W, Hackel DB, Harwood S, Wilson SGF, Hunter JLP (1959) Production of nephrotic syndrome in rats by Freund's adjuvant and rat kidney suspension. Proc Soc Exp Biol Med 100:660–664
Masugi M, Sato Y (1934) Über die allergische Gewebsreaktion der Niere. Zugleich ein experimenteller Beitrag zur Pathogenese der diffusen Glomerulonephritis und der Periarteriitis nodosa. Virchows Arch Pathol Anat Physiol Klin Med 293:615–664
Nagao T, Nagamatsu T, Suzuki Y (1994) Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats. Eur J Pharmacol 259:233–242
Nagao T, Nagamatsu T, Suzuki Y (1998) Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis in rats. Eur J Pharmacol 348:37–44
Theofilopoulos AN, Dixon FJ (1981) Etiopathogenesis of murine SLE. Immunological Rev 55:179–216
Unanue ER, Dixon FJ (1967) Experimental glomerulonephritis: Immunological events and pathogenic mechanisms. Adv Immunol 6:1–90
References
Chen Y-M, Chien C-T, Hu-Tsai M-I, Wu K-D, Tsai C-C, Wu M-S, Tsai T-J (1999) Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Intern 56:932–943
Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM (1978) Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 62:1275–1287
Eddington TS, Glassock RJ, Dixon FJ (1968) Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenic antigen. J Exp Med 127:555–572
Hamada N, Nagase M (1996) In vivo effect of OPC15161, a superoxide scavenger, on anti-Thy1 nephritis. Eur J Pharmacol 317:123–128
Hara M, Batsford SR, Mihatsch MJ, Bitter-Suermann D, Vogt A (1991) Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Labor Invest 65:168–179
Hayashi K, Nagematsu T, Honda S, Suzuki Y (1996) Butein (3,4,2′,4′-tertrahydroxychalcone) ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. Eur J Pharmacol 316:279–306
Heise G, Grabensee B, Schrör K, Heering P (1998) Different actions of the cyclooxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis. Nephron 80:220–226
Heymann W, Hackel DB, Harwood J, Wilson SGF, Hunter JLP (1959) Production of nephrotic syndrome in rats by Freund's adjuvant and rat kidney suspension. Proc Soc Exp Biol Med 100:660–668
Heymann W, Kmetec EP, Wilson SGF, Hunter JLP, Hackel DB, Okuda R, Cuppage F (1965) Experimental autoimmune renal disease in rats. Ann NY Acad Sci 124:310–315
Ito M, Yamada H, Okamoto K, Suzuki Y (1983) Crescentic type nephritis induced by anti-glomerular basement membrane (GBM) serum in rats. Jpn J Pharmacol 33:1145–1154
Kawasaki K, Yaoita E, Yamamoto T, Kihara I (1992) Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Intern 41:1517–1527
Kawasaki K, Yaoita E, Yamamoto T, Kihara I (1995) Therapeutic effect of combined treatment with monoclonal antibodies against intercellular adhesion molecule 1 and lymphocyte-function-associated antigen 1 in Masugi nephritis of Wistar-Kyoto rats. Nephron 71:101–102
Krakower CA, Greenspon SA (1951) Localization of nephrotoxic antigen within the isolated renal glomeruli. Arch Pathol 51:629–639
Kushiro M, Shikata K, Sugimoto H, Shikata Y, Miyatake N, Wada J, Miyasaka M, Makino H (1998) Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat. Kidney Intern 53:1314–1320
Masugi M, Sato T (1934) Virchows Arch Pathol Anat Physiol Klin Med 293:615
Nagamatsu T, Hayashi K, Oka T, Suzuki Y (1999) Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis. Eur J Pharmacol 374:93–101
Nagao T, Nagamatsu T, Suzuki Y (1994) Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats. Eur J Pharmacol 259:233–242
Nagao T, Nagamatsu T, Suzuki Y (1996) Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on passive Heymann nephritis in rats. Eur J Pharmacol 316:73–80
Nagao T, Nagamatsu T, Suzuki Y (1998) Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis in rats. Eur J Pharmacol 348:37–44
Okubo Y, Tsukada Y, Maezawa A, Ono K, Yano S, Naruse T (1990) FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. Clin Exp Immunol 82:450–455
Okuda S, Languino LR, Ruoslathi E, Border WA (1990) Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453–462
Rennke HG, Klein PS, Sandstrom DJ, Mendrick DL (1994) Cell-mediated immune injury in the kidney: Acute nephritis induced by azobenzenearsonate. Kidney Intern 45:1044–1056
Sanaka T, Nakano Y, Nishimura H, Shinobe M, Higuchi C, Omata M, Nihei H, Sugino N (1997) Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis. Nephron 76:315–322
Suzuki S, Gejyo F, Kuroda T, Kazama JJ, Imai N, Kimura H Arakawa M (1998) Effect of a new elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats. Kidney Intern 53:1291–1208
Tamatani T, Miyasaka M (1990) Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1 and evidence for differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 2:165–171
Thaiss F, Schoeppe W, Willaredt-Stoll JG, Batsford S, Mihatsch MJ (1989) Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats. Labor Invest 61:661–669
Unanue ER, Dixon FJ (1967) Experimental glomerulonephritis: Immunological events and pathogenic mechanisms. Adv Immunol 6:1–90
References
Abdel-Gayoum AA, El Jenjan KB, Ghwarsha KA (1999) Hyperlipidaemia in cisplatin-induced nephrotic rats. Hum Exp Toxicol 18:454–459
Asami T, Toyabe S, Uchiyama M (1999) Effects of glutathione on aminonucleoside nephrosis in rats. Acta Med Biol 47:9–14
Binder CJ, Weiher H, Exner M, Kerjaschki D (1999) Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria. A model of steroid-resistant nephrosis sensitive to radical scavenger therapy. Am J Pathol 154:1967–1075
Chagnac A, Korzets A, Ben Bassat M, Zevin D, Hirsh J, Meckler J, Levi J (1994) Uninephrectomy aggravates tubulointerstitial injury in rats with adriamycin nephrosis. Nephron 66:176–180
De Boer E, Navis G, Wapstra FH, De Jong PE, De Zeeuw D (1999) Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable. Kidney Intern 56, Suppl 71:S42–S46
Ebihara I, Nakamura T, Tomino Y, Koide H (1997) Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrol Dial Transplant 12:1001–1006
Guoji Y, Orita M, Tashiro K, Abe H (1994) Effects of glycyrrhetinic acid on aminonucleoside nephrosis in rats. Naunyn-Schmiedeberg's Arch Pharmacol 349:318–323
Kimura M, Takahashi H, Ohtake T, Sato T, Hishida A, Nishimura M, Honda H (1993) Interstrain differences in murine daunomycin-induced nephrosis. Nephron 63:193–198
Klar S, Morrissey JJ (1997) Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Intern 52, Suppl 63: S111–S114
Mackenzie HS, Ots M, Ziai F, Lee K-W, Kato S, Brenner BM (1997) Angiotensin receptor agonists in experimental models of chronic renal failure. Kidney Intern 52, Suppl 63:140–143
Magil A (1996) Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant. J Am Soc Nephrol 7:2340–2347
Milner LS, Wei SH, Houser MT (1991) Amelioration of glomerular injury in doxorubicin hydrochloride nephrosis by dimethylthiourea. J Lab Clin Med 118:427–434
Milner LS, Wei S, Kazakoff P, Watkins L, Houser MT (1994) Synergistic effect of fish oil diet and dimethylurea in acute adriamycin nephrosis. AM J Med Sci 308:266–270
Mizuno S, Mizuno-Horikawa Y, Yue B-F, Okamoto M, Kurosawa T (1999) Nephrotic mice (ICGN strain): A model of diffuse mesangial sclerosis in infantile nephrotic syndrome. Am J Nephrol 19:73–82
Mutti A, Coccini T, Alinovi R, Toubeau G, Broeckaert F, Bergamaschi E, Mozzoni P, Nonclercq D, Bernard A, Manzo L (1999) Exposure to hydrocarbons and renal disease: An experimental animal model. Renal Fail 21:369–385
Nosaka K, Takahashi T, Nishi T, Imaki H, Suzuki T, Suzuki K, Kurokawa K, Endou H (1997) An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity. Free Rad Biol Med 22:597–605
Park Y-S, Guijarro C, Kim Y, Massy CA, Kasiske BL, Keane WF, O'Donnell MP (1998) Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis 31:190–194
Pedraza-Chaverri J, Granados-Silvestre MA, Medina-Campos ON, Hernández-Pando R (1999) Effect of the in vivo catalase inhibition on aminonucleoside nephrosis. Free Rad Biol Med 27:245–253
Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D (1996) Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci 90:339–340
Yayama K, Kawao M, Tujii H, Itoh N, Okamoto H (1993) Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis. Eur J Pharmacol 236:337–338
Yoneda H, Toriumi W, Ohmachi Y, Okumura F, Fujimura H, Nishiyama S (1998) Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats. Eur J Pharmacol 362:213–219
References
Heinz F, Reckel S (1983) Xanthine oxidase In: Bergmeyer HU (ed) Methods of Enzymatic Analysis, Vol. III, 3rd edition. Verlag Chemie Weinheim, Deerfield Beach, Basel, pp 211–216
References
Dan T, Koga H (1990) Uricosurics inhibit urate transporter in renal brush border membrane vesicles. Eur J Pharmacol 187:303–312
Dan T, Onuma E, Tanaka H, Koga H (1991) A selective uricosuric action of AA-193 in rats. Comparison with its effect on PAH secretion in vivo and in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 343:532–537
Kahn AM, Branham S, Weinman EJ (1983) Mechanism of urate and p-aminohippurate transport in rat microvillus membrane vesicle. Am J Physiol 245 (Renal Fluid Electrolyte Physiol 14):F151–158
References
Baker KM, Hook JB, Williamson HE (1965) Saluretic action of ethacrynic acid in the mouse. J Pharm Sci 54:1830
Fanelli GM (1976) Drugs affecting the renal handling of uric acid. In. Martinez-Maldonado M (ed) Methods in Pharmacology Vol 4A: Renal Pharmacology Chapter 9, pp 269–292, Plenum Press, New York and London
Gutman AB, Yü TF (1961) A three-component system for regulation of renal excretion of uric acid in man. Trans Assoc Am Physicians 74:353–365
Hill TWK, Randall PJ (1976) A method for screening diuretic agents in the mouse: an investigation of sexual differences. J Pharm Pharmacol 28:552–554
Sim MF, Hopcroft RH (1976) Effect of various diuretic agents in the mouse. J Pharm Pharmacol 28:609–612
References
Hropot M, Sörgel F, v Kerékjártó B, Lang HJ, Muschaweck R (1980) Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat. In: Rapado A, Watts RWE, De Bruyn CHMM (eds) Purine Metabolism in Man — III A, Plenum Publishing Corp., New York, pp 269–276
Hropot M, Muschaweck R, Klaus E (1984) Uricostatic effect of allopurinol in the allantoxanamide-treated rat: A new approach for evaluation antiuricopathic drugs. In: DeBruyn CHMM, Simmonds HA, Muller MM (eds) Purine Metabolism in Man — IV, Part A, Plenum Publishing Corp., New York, pp 175–178
Johnson WJ, Chartrand A (1978) Allantoxanamide: a potent new uricase inhibitor in vivo. Life Sci 23:2239–2244
References
Bonardi G, Vidi A (1973) Action of 4-phenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) on an experimental hyperuricosuria in the rat. Pharm Res Comm 5:125–129
Dan T, Yoneya T, Onoma M, Onuma E, Ozawa K (1994) Hypouricemic and uricosuric actions of AA-193 in a hyperuricemic rat model. Metabolism 43:123–128
Hropot M, Sörgel F, v Kerékjártó B, Lang HJ, Muschaweck R (1980) Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat. In: Rapado A, Watts RWE, De Bruyn CHMM (eds) Purine Metabolism in Man — III A, Plenum Publishing Corp., New York, pp 269–276
Hropot M, Muschaweck R, Klaus E (1984) Uricostatic effect of allopurinol in the allantoxanamide-treated rat: A new approach for evaluation antiuricopathic drugs. In: DeBruyn CHMM, Simmonds HA, Muller MM (eds) Purine Metabolism in Man — IV, Part A, Plenum Publishing Corp., New York, pp 175–178
Johnson WJ, Stavric B, Chartrand A (1969) Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria. Proc Soc Exp Biol Med 131:8–12
Kageyama N (1971) A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system. Clin Chim Acta 31:421–426
Musil J (1977) Physiological characteristics of various experimental models for the study of disorders in purine metabolism. In: Müller MM, Kaiser E, Seegmiller JE (eds) Purine Metabolism in Man II — Physiology, Pharmacology and Clinical Aspects. Plenum Publishing Corp., New York, pp 179–188
Shinosaki S, Harada H, Yonetani Y (1991) Uricosuric property of a new diuretic compound, S-8666-S-(-)-enantiomer. Drug Dev Res 22:153–163
Stavric B, Clayman S, Gadd REA, Hébert D (1975) Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharm Res Comm 7:117–124
Sugino H, Shimada H (1995) The uricosuric effect in rats of E5050, a new derivative of ethanolamine, involves inhibition of the tubular postsecretory reabsorption of urate. Jpn J Pharmacol 68:297–303
Yonetani Y, Ikawi K, Shinosaki T, Kawase-Hanafusa A, Harada H, van Es AA (1987) A new uricosuric diuretic, S-8666, in rats and chimpanzees. Japan J Pharmacol 43:389–398
References
Kreppel E (1959) Der Einfluß einiger Phenylbutazonderivate auf den Phenolrotblutspiegel der Ratte. Med Exp 1:285–289
Scarborough HC, McKinney GR (1962) Potential uricosuric agents derived from 1,3-diphenyl-barbituric acid. J Med Pharm Chem 5:175–183
Turner RA (1965) Uricosuric agents In: Screening Methods in Pharmacology Chapter 39, pp 262–263, Academic Press, New York and London
References
Fanelli GM (1976) Drugs affecting the renal handling of uric acid. In: Martinez-Maldonado M (ed) Methods in Pharmacology, Vol 4A, Renal Pharmacology, Chapter 9, pp 269–292
Friedman M, Byers SO (1948) Observations concerning the causes of the excess excretion of uric acid in the Dalmatian dog. J Biol Chem 175:727–735
Hropot M, Klaus E, Seuring B, Lang HJ (1985) Effects of diuretics on magnesium excretion. Magnesium Bull 7:20–24
Kessler RH, Hierholzer K, Gurd RS (1959) Localization of urate transport in the nephron of mongrel and Dalmatian dog kidney. Am J Physiol 197:601–603
Muschaweck R, Hajdu P (1964) Die saludiuretische Wirksamkeit der Chlor-N-(2-furylmethyl)-5-sulfamyl-anthranilsäure. Arzneim Forsch/Drug Res 14:44–47
Yü TF, Gutman AB, Berger L, Kaung C (1971) Low uricase activity in the Dalmatian dog simulated in mongrels given oxonic acid. Am J Physiol 220:973–979
References
Dan T, Koga H, Onuma E, Tanaka H, Sato H, Aoki B (1989) The activity of AA-193, a new uricosuric agent in animals. Adv Exp Med Biol 253:301–308
Fanelli GM (1976) Drugs affecting the renal handling of uric acid. In: Martinez-Maldonado M (ed) Methods in Pharmacology, Vol 4A, Renal Pharmacology, Chapter 9, pp 269–292
Fanelli GM, Bohn D, Stafford SH (1970) Functional characteristics of renal urate transport in the Cebus monkey. Am J Physiol 218:627–636
Hropot M (1988) Unpublished data
Onuma E, Tanaka H, Takahashi F, Tatsumi T, Akaike I, Koga H, Dan T (1988) Uricosuric effect of a new aryloxyacetic derivative (AA-193) in rats and Cebus monkeys. Jpn J Pharmacol 46(Suppl):Abst. P-250
Yonetani Y, Ikawi K, Shinosaki T, Kawase-Hanafusa A, Harada H, van Es AA (1987) A new uricosuric diuretic, S-8666, in rats and chimpanzees. Japan J Pharmacol 43:389–398
Yü TF, Gutman AB, Berger L, Kaung C (1971) Low uricase activity in the Dalmatian dog simulated in mongrels given oxonic acid. Am J Physiol 220:973–979
References
Anderson KE (1993) Pharmacology of lower urinary tract muscles and penile erectile tissues. Pharmacol Rev 46:253–308
Angelico P, Guarneri L, Fredella B, Testa R (1992) In vivo effects of different antispasmodic drugs on the rat bladder contractions induced by topically applied KCl. J Pharmacol Meth 27:33–39
Conte B, D'Aranno V, Santicioli P, Giuliani S, Mancinelli A, Furio M, Maggi CA, Meli A (1988) A new method for recording cystometrograms in conscious, freely moving rats. J Pharmacol Meth 19:57–61
Conte B, Maggi CA, Parlani M, Lopez G, Manzini S, Giachetti A (1991) Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: Effect of neuromuscular blocking agents on the activity of the external urethral sphincter. J Pharmacol Meth 26:161–171
De Groat WC (1975) Nervous control of the urinary bladder of the cat. Brain Res 87:201–211
Dray A (1995) The rat urinary bladder. A novel preparation for the investigation of central opioid activity in vivo. J Pharmacol Meth 13:157–165
Ferguson D, Christopher N (1996) Urine bladder function and drug development. Trends Pharmacol Sci 17:161–165
Häbler HJ, Jänig W, Koltzenburg M (1990) Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol 425:545–562
Häbler HJ, Jänig W, Koltzenburg M (1992) Myelinated primary afferents of the sacral spinal cord responding to slow filling and distension of the cat urinary bladder. J Physiol 463:449–460
Harada T, Levounis P, Constantinou CE (1992) Rapid evaluation of the efficacy of pharmacologic agents and their analogs in enhancing bladder capacity and reducing the voiding frequency. J Pharmacol Toxicol Meth 27:119–126
Horváth G, Morvay Z, Kovács M, Szikszay M, Benedek G (1994) An ultrasonic method for the evaluation of dexmedetomidine on micturition in intact rats. J Pharmacol Toxicol Meth 32:215–218
Imagawa JI, Akima M, Sakai K (1989) Functional evaluation of sympathetically mediated responses in vivo lower urinary tract of dogs. J Pharmacol Meth 22:103–111
Kuro M (1965) Nervous control of micturition. Physiol Rev 45:425–494
Maggi CA (1992) Prostanoids as local modulators of reflex micturition. Pharmacol Res 25:13–20
Maggi CA, Santicioli P, Grimaldi G, Meli A (1983) The effect of peripherally administered GABA on spontaneous contractions of rat urinary bladder in vivo. Gen Pharmacol 14:455–458
Maggi CA, Santicioli P, Furio M, Meli A (1985) Dual effects of clonidine on micturition reflex in urethane anesthetized rats. J Pharmacol Exper Ther 235:528–536
Maggi CA, Santicioli P, Meli A (1986) The nonstop transvesical cystometrogram in urethane-anesthetized rats: A simple procedure for quantitative studies on the various phases of urinary bladder voiding cycle. J Pharmacol Meth 15:157–167
Maggi CA, Santicioli P, Meli A (1987a) Pharmacological studies on factors influencing the collecting phase of the cystometrogram in urethane-anesthetized rats. Drug Dev Res 10:157–170
Maggi CA, Giuliani S, Santicioli P, Abelli L, Regoli D, Meli A (1987b) Further studies on the mechanisms of the tachykinin-induced activation of the micturition reflex in rats: evidence for the involvement of the capsaicin-sensitive bladder mechanoreceptors. Eur J Pharmacol 136:189–205
Moreau PM, Lees GE, Gross DR (1983) Simultaneous cystometry and uroflowmetry (micturition study) for evaluation of the caudal part of the urinary tract in dogs: Reference values for healthy animals sedated with xylazine. Am J Vet Res 44:1774–1781
Noronha-Blob L, Prosser JC, Sturm BL, Lowe VC, Enna SJ (1991) (±)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion. Eur J Pharmacol 201:135–142
Oyasu H; Yamamoto T, Sato N, Sawada T, Ozaki R, Mukai T, Ozaki T, Nishii M, Sato H, Fujiwara T, Tozuka Z, Koibuchi Y, Honbo T, Esumi K, Ohtsuka M, Shimomura K (1994) Urinary bladder-selective action of the new antimuscarinic compound vamicamide. Arzneim Forsch/Drug Res 44:1242–1249
Peterson JS, Hanson RC, Noronha-Blob L (1989) In vivo cystometrogram studies in urethane-anesthetized and conscious guinea pigs. J Pharmacol Meth 21:231–241
Pietra C, Poggesi E, Angelico P, Guarneri L, Testa R (1990) Effects of some antidepressants on the volume-induced reflex contractions of the rat urinary bladder: lack of correlation with muscarinic receptors activity. Pharmacol Res 22:421–432
Postius S, Szelenyi I (1983) In vivo rat bladder: a new model to screen spasmolytic compounds. J Pharmacol Meth 9:53–61
Tillig B, Constantinou CE (1996) Videomicroscopic imaging of ureteral peristaltic function in rats during cystometry. J Pharmacol Toxicol Meth 35:191–202
Yaksh TL, Durant PAC, Brent CR (1986) Micturition in rats: a chronic model for study of bladder function and effect of anesthetics. Am J Physiol 251 (Regulative Integrative Comp Physiol 20):R1177–R1185
References
Bigoni R, Guiliani S, Calo G, Rizzi A, Guerrini R, Salvadori S, Regoli D, Maggi CA (1999) Characterization of nociceptin receptors in the periphery: In vitro and in vivo studies. Naunyn-Schmiedeberg's Arch Pharmacol 359:160–167
Giuliani S, Maggi CA (1996) Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol 118:1567–1569
Kimoto Y, Constantinou CE (1990) Effects of (1-desamino-8-D-arginine)vasopressin and papaverine on rabbit renal pelvis. Eur J Pharmacol 175:359–362
Kimoto Y, Constantinou CE (1991) Regional effects of indomethacin, acetylsalicylic acid and SC-19220 on the contractility of rabbit renal pelvis (pacemaker regions and pelviureteric junction). J Urol 146:433–438
Kondo S, Tashima Y, Morita T (1992) Effects of dobutamine and terbutaline on adenylate cyclase activity and cyclic AMP content in the renal pelvis of rabbits. Urol Int 49:146–150
Lang RJ, Zhang Y (1996) The effects of K+ channel blockers on the spontaneous electrical and contractile activity in the proximal renal pelvis of the guinea pig. J Urol 155:332–336
Lang RJ, Zhang Y, Exintaris B, Vogalis F (1995) Effects of nerve stimulation on the spontaneous action potentials recorded in the proximal renal pelvis of the guinea pig. Urol Res 23:343–350
Maggi CA, Giuliani S (1991) The neurotransmitter role of CGRP in the rat and guinea pig ureter: effect of a CGRP agonist and species-related differences in the action of omega conotoxin on CGRP release from primary afferents. Neuroscience 43:261–271
Maggi CA, Giuliani S (1992) Non-adrenergic, non-cholinergig excitatory innervation of the guinea pig renal pelvis: Involvement of capsaicin-sensitive primary afferent neurons. J Urol 147:1394–1398
Maggi CA, Patacchini R, Eglezos A, Quartara L, Giuliani S, Giachetti A (1992a) Tachykinin receptors in the guinea pig renal pelvis: Activation by exogenous and endogenous tachykinins. Br J Pharmacol 107:27–33
Maggi CA, Santicioli P, Del Bianco E, Giuliani S (1992b) Local motor responses to bradykinin and bacterial chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP) in the guinea pig isolated renal pelvis and ureter. J Urol 14:1944–1950
Maggi CA, Theodorsson E, Santicioli P, Giuliani S (1992c) Tachykinins and calcitonin gene-related peptide as co-transmitters in local responses produced by sensory nerve activation in the guinea pig isolated renal pelvis. Neuroscience 46:549–559
Maggi CA, Giuliani S, Santicioli P (1994) Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea pig isolated renal pelvis and ureter. Br J Pharmacol 111:687–794
Maggi CA, Giuliani S, Santicioli P (1995) CGRP inhibits electromechanical coupling in the guinea pig isolated renal pelvis. Naunyn-Schmiedeberg's Arch Pharmacol 352:529–537
Patacchini R, Santicioli P, Zagorodnyuk V, Lazzeri M, Turini D, Maggi CA (1998) Excitatory motor and electrical effects produced by tachykinins in the human and guinea pig isolated ureter and guinea pig renal pelvis. Br J Pharmacol 125:987–996
Santicioli P, Maggi CA (1997) Pharmacological modulation of electromechanical coupling in the proximal and distal regions of the guinea pig pelvis. J Auton Pharmacol 17:43–52
Santicioli P, Carganico G, Meini S, Giuliani S, Giachetti A, Maggi CA (1995) Modulation of stereoselective inhibition of cyclo-oxygenase of electromechanical coupling in the guinea pig isolated renal pelvis. Br J Pharmacol 114:1149–1158
Seki N, Suzuki H (1990) Electrical properties of smooth muscle cell membrane in renal pelvis of rabbits. Am J Physiol 259 (Renal, Fluid, Electrolyte Physiol 28):F888–F894
Teele ME, Lang RJ (1998) Stretch-evoked inhibition of spontaneous migrating contractions in whole mount preparation of the guinea pig upper urinary tract. Br J Pharmacol 123:1143–1153
Zhang Y, Lang RJ (1994) Effect of intrinsic prostaglandins on the spontaneous contractile and electrical activity of the proximal renal pelvis of the guinea pig. Br J Pharmacol 113:431–438
Zwergel U, Zwergel T, Ziegler M (1991) Effects of prostaglandins and prostaglandin synthetase inhibitors on acutely obstructed kidneys in the dog. Urol Int 47:64–69
References
Anderson GF (1978) The rabbit detrusor muscle: a unique in-vitro smooth muscle preparation. J Pharmacol Meth 1:177–182
Andersson KE, Mattiasson A, Sjögren S (1983) Electrically induced relaxation of the noradrenaline contracted isolated urethra from rabbit and man. J Urol 129:210–214
Andersson KE, Pascual AG, Persson K, Forman A, Tøttrup A (1992) Electrically-induced, nerve-mediated relaxation of rabbit urethra involves nitric oxide. J Urol 147:253–259
Angelico P, Guarneri L, Fredella B, Testa R (1992) In vivo effects of different antispasmodic drugs on the rat bladder contractions induced by topically applied KCl. J Pharmacol Meth 27:33–39
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48–58
Burnstock G, Cocks T, Crowe R, Kasakov L (1978) Purinergic innervation of the guinea pig urinary bladder. Br J Pharmacol 63:125–138
Dhattiwala AS, Dave KC (1975) Isolated innervated, rat and guinea pig hemi-urinary bladder preparations. Ind J Physiol Pharmacol 19:164–166
Ferguson DR, Marchant JS (1995) Inhibitory actions of GABA on rabbit urinary bladder muscle strips: mediation by potassium channels. Br J Pharmacol 115:81–83
Hills J, Meldrum LA, Klarskov P, Burnstock G (1984) A novel non-adrenergic, non-cholinergic nerve-mediated relaxation of the pig bladder neck: an examination of possible neurotransmitter candidates. Eur J Pharmacol 99:287–293
Honda K, Nakagawa C (1986) Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate. J Pharmacol Exper Ther 239:512–516
Hukovic S, Rand MJ, Vanov S (1965) Observations on an isolated, innervated preparation of rat urinary bladder. Br J Pharmacol 24:178–188
Khanna OP, diGregorio GJ, Sample RG, McMichael R (1977) Histamine receptors in urethrovesical smooth muscle. Urology 10:375–381
Khanna OP, Barbieri EJ, McMichael RF (1981) The effects of adrenergic agonists and antagonists on vesicourethral smooth muscle of rabbits. J Pharmacol Exp Ther 216:95–100
Klarskov P (1987) Non-cholinergic, non-adrenergic inhibitory nerve responses of bladder outlet smooth muscle in vitro. Br J Urology 60:337–342
Kunisawa Y, Kawabe K, Nijima T, Honda K, Takenaka T (1985) A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol 134:396–398
Maggi CA, Santicioli P, Furio M, Meli A (1985) Dual effects of clonidine on micturition reflex in urethane anesthetized rats. J Pharmacol Exper Ther 235:528–536
Mapp CE, Chitano P, Fabbri LM, Patacchini R, Maggi CA (1990) Pharmacological modulation of the contractile response to toluene diisocyanate in the rat isolated urinary bladder. Br J Pharmacol 100:886–888
Pietra C, Poggesi E, Angelico P, Guarneri L, Testa R (1990) Effects of some antidepressants on the volume-induced reflex contractions of the rat urinary bladder: lack of correlation with muscarinic receptors activity. Pharmacol Res 22:421–432
Santicioli P, Maggi CA, Meli A (1984) GABAB receptor mediated inhibition of field stimulation-induced contractions of rabbit bladder muscle in vitro. J Pharm Pharmacol 36:378–381
Teramoto N, Creed KE, Brading AF (1997) Activity of gliben-clamide-sensitive K+ channels under unstimulated conditions in smooth muscle cells of pig proximal urethra. Naunyn-Schmiedeberg's Arch Pharmacol 356:418–424
Thornbury KD, Hollywood MA, McHale NG (1992) Mediation of nitric oxide of neurogenic relaxation of the urinary bladder neck muscle in sheep. J Physiol 451:133–144
Ueda S, Satakee N, Shibata S (1984) α1-and α2-adrenoreceptors in the smooth muscle of isolated rabbit urinary bladder and urethra. Eur J Pharmacol 103:249–254
Von Heyden B, Jordan U, Schmitz W, Hertle L (1997) Urethral relaxation after electrostimulation in the guinea pig is independent of nitric oxide. J Urology 157:1509–1513
Weetman DF (1972) The guinea-pig isolated, innervated bladder preparation: the effect of some autonomic drugs. Arch Int Pharmacodyn 196:383–392
References
Hulsebosh CE, Goggeshall RE (1982) An analysis of the axon population in the nerves to the pelvic viscera in the rat. J Comp Neurol 211:1–10
Kuro M (1965) Nervous control of micturition. Physiol Rev 45:425–494
Parlani M, Manzini S, Argentino-Storino A, Conte B (1992) The rat external urethral sphincter. An in vitro model to evaluate the activity of drugs on the smooth and striated components of the urinary bladder outlet. J Pharmacol Toxicol Meth 28:85–90
Purinton PT, Fletcher TF, Bradley WE (1973) Gross and light microscopy features of the pelvic plexus in the rat. Anat Rec 175:697–706
Somma V, Conte B, Lopez G, Astolfi MI (1989) A method for complete removal of pelvic ganglia in female rats. J Pharmacol Meth 22:243–247
Watanabe H, Yamamoto TY (1979) Autonomic innervation of the muscle in the wall of the bladder and proximal urethra of male rats. J Anatomy 128:873–886
References
Brading AF, Burdyga ThV, Scripnyuk ZD (1983) The effects of papaverine on the electrical and mechanical activity of the guinea pig ureter. J Physiol 334: 79–89
Meini S, Santicioli P, Maggi CA (1995) Propagation of impulses in the guinea pig ureter and its blockade by calcitonin-generelated peptide. Naunyn-Schmiedeberg's Arch Pharmacol 351:79–86
Shuba MF (1977) The effect of sodium free and potassium-free solutions, ionic current inhibitors and ouabain on electrophysiological properties of smooth muscle of guinea pig ureter. J Physiol 264:837–851
Weiss RM (1992) Physiology and pharmacology of renal pelvis and ureter. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campell's Urology. WB Saunders Co. Philadelphia PA, Vol 1, pp 113–144
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag
About this entry
Cite this entry
Vogel, H.G., Vogel, W.H., Schölkens, B.A., Sandow, J., Müller, G., Vogel, W.F. (2002). Activity on urinary tract1 . In: Vogel, H.G., Vogel, W.H., Schölkens, B.A., Sandow, J., Müller, G., Vogel, W.F. (eds) Drug Discovery and Evaluation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29837-1_4
Download citation
DOI: https://doi.org/10.1007/3-540-29837-1_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42396-6
Online ISBN: 978-3-540-29837-3
eBook Packages: Springer Book Archive